VitaNova Life Sciences (VNOV) Current Assets (2017 - 2026)

VitaNova Life Sciences has reported Current Assets for 9 years, with the latest figure at $2.3 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 74.99% year-over-year to $2.3 million; the trailing twelve-month figure through Jan 2026 stood at $2.3 million (up 74.99% YoY), and the FY2025 full-year result was $2.3 million, up 89.15% from the prior year.
• Current Assets for Q1 2026 stood at $2.3 million, down from $2.3 million in the prior quarter.
• The five-year high for Current Assets was $2.3 million in Q4 2025, with the low at $8728.0 in Q2 2023.
• Historically, Current Assets has averaged $1.0 million across 5 years, with a median of $1.2 million in 2024.
• Annual changes were most pronounced in 2023 — Current Assets plunged 73.97% — and 2024, when it soared 13567.03%.
• VitaNova Life Sciences' Current Assets stood at $35190.0 in 2022, then sank by 75.2% to $8728.0 in 2023, then soared by 14322.69% to $1.3 million in 2024, then surged by 85.59% to $2.3 million in 2025, then dropped by 1.05% to $2.3 million in 2026.
• The last three Current Assets figures came in at $2.3 million (Q1 2026), $2.3 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.